Close Menu

NEW YORK (GenomeWeb) – Clinical Genomics has closed a $15 million Series A financing round, and plans to use the proceeds to help commercialize its blood test for post-surgical monitoring of colorectal cancer occurrence.

OneVentures, a venture capital firm based in Sydney, Australia, led the financing. In connection with the funding, OneVentures Partner and Managing Director Paul Kelly will join Clinical Genomics' board.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Sponsored by

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.